You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Enterobacter Bacteremia

An Analysis of 50 Episodes

Emilio Bouza, MD; Manuel García de la Torre, MD; Alejo Erice, MD; Elena Loza, MD; José María Diaz-Borrego, MD; Luis Buzón, MD

Arch Intern Med. 1985;145(6):1024-1027.


Abstract

• During a six-year period, 147 patients had Enterobacter bacteremia (3.8% of the episodes of bacteremia), with an incidence of 1.25 per 1,000 admitted patients. We chose a random group of 50 cases for analysis. The disease was community acquired in 24% of the cases and nosocomially acquired in the remaining 76%. The bacteremia was unimicrobial in 70% and part of a polymicrobial bacteremia in 30%. The species most commonly causing bacteremia was Enterobacter cloacae. Portals of entry, in decreasing order of frequency, were unknown, surgical wound, respiratory tract, and urinary tract. The most common clinical finding was fever (92%). Shock occurred in 30% of the patients, and only two patients had evidence of disseminated intravascular coagulation. Of the Enterobacter isolates, 12% were resistant to gentamicin. Overall mortality was 42%; factors associated with a poor prognosis were inadequacy of antimicrobial chemotherapy, septic shock, type of underlying disease, clinical condition, and requirement of intensive care.

(Arch Intern Med 1985;145:1024-1027)



Author Affiliations

From the Infectious Disease Unit (Drs Bouza, Garcóa la Torre, Erice, and Buzón), Microbiology Service (Dr Loza), and Intensive Care Unit (Dr Diaz-Borrego), Centro Especial "Ramón y Cajal," Madrid.


Footnotes

Accepted for publication Aug 23, 1984.

Reprint requests to Servicio de Microbiología Clínica, Hospital Provincial de Madrid, Calle Ibiza, Madrid 28007, Spain (Dr Bouza).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia
Marcos et al.
J Antimicrob Chemother 2008;62:397-403.
ABSTRACT | FULL TEXT  

Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow et al.
ANN INTERN MED 1991;115:585-590.
ABSTRACT  

Enterobacter Cloacae Bacteremia in Children: A Review of 30 Cases in 12 Years
Bonadio et al.
CLIN PEDIATR 1991;30:310-313.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.